Recombinant Human PILRA Protein，GST

PILRA (Paired Immunoglobulin-like Type 2 Receptor Alpha) is a member of the immunoglobulin superfamily and is primarily expressed in immune cells, particularly in myeloid lineage cells. This receptor plays a crucial role in regulating immune responses, particularly in the context of inflammation and autoimmune diseases. Research has indicated that PILRA can modulate the activation of various immune pathways, influencing the balance between pro-inflammatory and anti-inflammatory signals. Furthermore, dysregulation of PILRA expression has been linked to several pathological conditions, including cancer and infectious diseases, making it an attractive target for therapeutic interventions. The recombinant expression of PILRA protein has enabled researchers to study its functional properties, signaling mechanisms, and interactions with other immune receptors, facilitating the understanding of its role in immune regulation. Advances in protein engineering and purification methods have allowed for the production of high-quality PILRA recombinant proteins, which are essential for both in vitro and in vivo studies. Investigating PILRA's biological functions can provide insights into potential therapeutic strategies, including the development of modulators that could enhance immune responses in cancer therapies or dampen excessive inflammation in autoimmune disorders. Thus, the study of PILRA, through recombinant protein research, holds significant promise for improving our understanding and treatment of various immune-related conditions.